跳至主要内容
临床试验/NCT00247455
NCT00247455已完成不适用

Long-term Effect of Cereal Fibre on Abdominal Fat in Insulin Resistant Subjects

University of Toronto2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2002年3月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
Serum acetate concentration

研究概览

简要总结

High intake of cereal fibre has been shown to be associated with reduced weight gain and improved insulin sensitivity. We hypothesize these effects are due to the short chain fatty acids derived from the bacterial fermentation (breakdown) of fibre in the colon (large intestine). Insulin resistant subjects will be randomized to receive 2 servings of a low-fibre cereal (eg. puffed rice) or 2 servings of a high-fibre cereal (wheat bran cereal) per day for one year. The effects of the diets on body weight, appetite, abdominal fat, blood short chain fatty acids, glucose, insulin, lipids and hormones will be measured

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Non-diabetic male or non-pregnant females
  • aged 18-60
  • fasting insulin >40pmol/L (70%ile)

排除标准

  • intention to lose >5kg in weight
  • presence of diabetes (fasting glucose >6.9mmol/L)
  • use of diuretics, beta-blockers or weight reducing drugs
  • use of antibiotics in last 3 months and use of antibiotics more than once annually for the last 2 years
  • significant gastrointestinal, liver or kidney disease
  • use of lipid-lowering drug
  • major medical or surgical event in last 6 mo.
  • fibre intake >30g/d
  • inability to eat low or high fibre breakfast cereals
  • unwilling or unable to give consent or comply with protocol

结局指标

主要结局

Serum acetate concentration

时间窗: 0, 3, 6, 9 and 12 months

Serum butyrate concentration

时间窗: 0, 3, 6, 9 and 12 months

Plasma GLP-1 concentration

时间窗: 0, 3, 6, 9 and 12 months

次要结局

  • HOMA insulin resistance and beta cell function(0, 3, 6, 9 and 12 months)
  • postprandial glucose and insulin(0, 3, 6, 9 and 12 months)
  • Fasting glucose and insulin(0, 3, 6, 9 and 12 months)
  • Body weight(0, 3, 6, 9 and 12 months)
  • waist circumference(0, 3, 6, 9 and 12 months)
  • Abdominal fat(0 and 12 months)
  • food intake(0, 3, 6, 9 and 12 months)
  • Fasting lipids (cholesterol, triglyceride, HDL, LDL)(0, 3, 6, 9 and 12 months)
  • Fasting and postprandial free fatty acids and triglycerides(0, 3, 6, 9 and 12 months)
  • Fasting and postprandial c-peptide(0, 3, 6, 9 and 12 months)
  • C-peptide/insulin ratio as marker of hepatic insulin extraction(0, 3, 6, 9 and 12 months)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验